Using real-world data, researchers identified patterns of use of medically dispensed cannabis in patients with inflammatory bowel disease, according to a poster presented at the ACG Annual Scientific Meeting.

“We know that cannabis use in IBD patients is common and that many report improvement in IBD-related symptoms, including mitigation of pain,” Jami A.R. Kinnucan, MDFACG, assistant professor of medicine at the University of Michigan, said during a virtual presentation. “However, patterns of cannabis use, including dose and route of administration, have not been described

Full Article: